FDA urges drugmakers to add new label info on antidepressant risks
New information concerning risks to newborns and migraine sufferers should be added to the labels of selective serotonin reuptake inhibitors ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.